2025 annual financial data
Xeris Biopharma Holdings 2025 Operating margin
Direct answer
Operating margin was 8.53%.
Operating income was 24,896,000 USD and net income was 554,000 USD.
Operating cash flow was 28,626,000 USD.
Get free Xeris Biopharma Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 291,845,000 USD
- Operating income
- 24,896,000 USD
- Net income
- 554,000 USD
- Operating cash flow
- 28,626,000 USD